+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Polymerase Chain Reaction Technologies Market by Technology, Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4612802
  • Report
  • Region: Global
  • 237 pages
  • Allied Analytics LLP
1 of 3
Polymerase chain reaction (PCR) is an important scientific technique in molecular biology that amplifies single or few copies of a piece of DNA. In addition, it is helpful in generating thousands to millions of copies of a particular DNA sequence and investigating diseases such as AIDS, tuberculosis, Lyme disease, and middle ear infections. The technology involves three major steps-denaturation, annealing, and extension. It is applicable in medical, research, clinical diagnostics, and forensics. It has been utilized since decades as a standard method for research on nucleic acids (RNA and DNA) in laboratories. PCR technologies available in market are real-time quantitative (qPCR), digital PCR (dPCR), inverse PCR, multiplex PCR, assembly PCR, and standard PCR. The need of effective diagnostic molecular technique in healthcare to detect diseases fuels the demand for the growth of the market. The global polymerase chain reaction technologies market was valued at $7,027 million in 2016, and is estimated to reach $10,776 million by 2023, registering a CAGR of 6.2% from 2017 to 2023.

Rise in number of diagnostic centers and hospitals, completion of the human genome project, high prevalence of diseases, increase in the geriatric population, technological advancements, and high investments by private and public organizations drive the market. However, technical limitations related to qPCR and dPCR products and high cost of dPCR devices restraint the market growth. In addition, accurate and timely results for RT-PCR is a major challenge faced by the PCR market. Reduction in number of PCR processes makes the process less tedious and may open avenues of opportunities for the PCR market.

The report segments the market by technology, product, end user, application, and geography. In terms of technology, it is segmented into real-time PCR, traditional PCR, and digital PCR. Based on product, it is classified into reagents & consumables, instruments, software, and services. Based on application, it is categorized into clinical, research, and forensic applications. Based on end user, it is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Healthcare giants have adopted product developments & commercialization, collaborations, partnerships, and agreements as their key strategic moves for the development of their portfolios. For instance, LGC Ltd. acquired Biosearch Technologies in 2015 to extend its expertise in qPCR market. Moreover, Sygnis AG launched SunScript one-step RT-qPCR kit in January 2016, which is useful in gene expression analysis. These developments by market giants have led to the market growth.

KEY BENEFITS FOR STAKEHOLDERS

This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to technology, product, end user, application, and geography.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY PLAYERS PROFILED

Thermo Fisher Scientific Inc.
Sygnis AG
LGC Ltd.
Bio-Rad Laboratories Inc.
Agilent Technologies, Inc.
BioMerieux S.A.
RainDance Technologies, Inc.
Affymetrix Inc.
Fluidigm Corporation
Takara Bio Inc.

KEY MARKET SEGMENTS

By Technology

Real-time PCR
Traditional PCR
Digital PCR

By Product

Reagents & Consumables
Instruments
Software
Services

By Application

Clinical
Research
Forensic

By End Users

Diagnostic Centers & Hospitals
Biotech & Pharma Companies
Academic & Research Institutions

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA

The other players of the polymerase chain reaction technologies market include (companies not profiled in the report):

Beckman Coulter
Becton, Dickinson and Company
Cepheid
Clontech Laboratories
Eppendorf
Fluidigm
GE Healthcare
Kapa Biosystems
Maxim Biotech
PerkinElmer
Promega
Siemens Healthcare
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top Winning Strategies
3.2.2. Top investment pockets, 2016
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. GOVERNMENT REGULATIONS
3.5.1. U.S. FDA
3.5.2. Europe- CE Mark and European Medicines Agency (EMA)
3.5.3. Ministry of Health, Labour, and Welfare (MHLW) and Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Rise in prevalence of infectious diseases and cancer
3.6.1.2. Increase in awareness and acceptance of personalized medicines
3.6.1.3. Technological Advancements
3.6.2. Restraints
3.6.2.1. Growth of non-validated home brew test
3.6.2.2. Reimbursement issues
3.6.3. Opportunities
3.6.3.1. Increase in funding for R&D activities
3.6.3.2. Untapped markets in developing economies

CHAPTER 4 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market Size and Forecast
4.2. REAL-TIME PCR
4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast
4.3. TRADITIONAL PCR
4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast
4.4. DIGITAL PCR
4.4.1. Key Market Trends and Opportunities
4.4.2. Market Size and Forecast

CHAPTER 5 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market Size and Forecast
5.2. REAGENTS & CONSUMABLES
5.2.1. Market Size and Forecast
5.3. INSTRUMENTS
5.3.1. Market Size and Forecast
5.4. SOFTWARE
5.4.1. Market Size and Forecast
5.5. SERVICES
5.5.1. Market Size and Forecast

CHAPTER 6 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market Size and Forecast
6.2. CLINICAL
6.2.1. Market Size and Forecast
6.3. RESEARCH
6.3.1. Market Size and Forecast
6.4. FORENSICS
6.4.1. Market Size and Forecast

CHAPTER 7 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market Size and Forecast
7.2. DIAGNOSTIC CENTERS & HOSPITALS
7.2.1. Market Size and Forecast
7.3. BIOTECH & PHARMA COMPANIES
7.3.1. Market Size and Forecast
7.4. ACADEMIC & RESEARCH INSTITUTIONS
7.4.1. Market Size and Forecast

CHAPTER 8 POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast by country
8.2.4. Market size and forecast by Technology
8.2.5. Market size and forecast by Product
8.2.6. Market size and forecast by Application
8.2.7. Market size and forecast by End Users
8.2.7.1. U.S. market size and forecast by Technology
8.2.7.2. U.S. market size and forecast by Product
8.2.7.3. U.S. market size and forecast by Application
8.2.7.4. U.S. market size and forecast by End Users
8.2.7.5. Canada market size and forecast by Technology
8.2.7.6. Canada market size and forecast by Product
8.2.7.7. Canada market size and forecast by Application
8.2.7.8. Canada market size and forecast by End Users
8.2.7.9. Mexico market size and forecast by Technology
8.2.7.10. Mexico market size and forecast by Product
8.2.7.11. Mexico market size and forecast by Application
8.2.7.12. Mexico market size and forecast by End Users
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast by country
8.3.4. Market size and forecast by Technology
8.3.5. Market size and forecast by Product
8.3.6. Market size and forecast by Application
8.3.7. Market size and forecast by End Users
8.3.7.1. Germany market size and forecast by Technology
8.3.7.2. Germany market size and forecast by Product
8.3.7.3. Germany market size and forecast by Application
8.3.7.4. Germany market size and forecast by End Users
8.3.7.5. France market size and forecast by Technology
8.3.7.6. France market size and forecast by Product
8.3.7.7. France market size and forecast by Application
8.3.7.8. France market size and forecast by End Users
8.3.7.9. UK market size and forecast by Technology
8.3.7.10. UK market size and forecast by Product
8.3.7.11. UK market size and forecast by Application
8.3.7.12. UK market size and forecast by End Users
8.3.7.13. Italy market size and forecast by Technology
8.3.7.14. Italy market size and forecast by Product
8.3.7.15. Italy market size and forecast by Application
8.3.7.16. Italy market size and forecast by End Users
8.3.7.17. Spain market size and forecast by Technology
8.3.7.18. Spain market size and forecast by Product
8.3.7.19. Spain market size and forecast by Application
8.3.7.20. Spain market size and forecast by End Users
8.3.7.21. Rest of Europe market size and forecast by Technology
8.3.7.22. Rest of Europe market size and forecast by Product
8.3.7.23. Rest of Europe market size and forecast by Application
8.3.7.24. Rest of Europe market size and forecast by End Users
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast by country
8.4.4. Market size and forecast by Technology
8.4.5. Market size and forecast by Product
8.4.6. Market size and forecast by Application
8.4.7. Market size and forecast by End Users
8.4.7.1. Japan market size and forecast by Technology
8.4.7.2. Japan market size and forecast by Product
8.4.7.3. Japan market size and forecast by Application
8.4.7.4. Japan market size and forecast by End Users
8.4.7.5. China market size and forecast by Technology
8.4.7.6. China market size and forecast by Product
8.4.7.7. China market size and forecast by Application
8.4.7.8. China market size and forecast by End Users
8.4.7.9. Australia market size and forecast by Technology
8.4.7.10. Australia market size and forecast by Product
8.4.7.11. Australia market size and forecast by Application
8.4.7.12. Australia market size and forecast by End Users
8.4.7.13. India market size and forecast by Technology
8.4.7.14. India market size and forecast by Product
8.4.7.15. India market size and forecast by Application
8.4.7.16. India market size and forecast by End Users
8.4.7.17. South Korea market size and forecast by Technology
8.4.7.18. South Korea market size and forecast by Product
8.4.7.19. South Korea market size and forecast by Application
8.4.7.20. South Korea market size and forecast by End Users
8.4.7.21. Taiwan market size and forecast by Technology
8.4.7.22. Taiwan market size and forecast by Product
8.4.7.23. Taiwan market size and forecast by Application
8.4.7.24. Taiwan market size and forecast by End Users
8.4.7.25. Rest of Asia-Pacific market size and forecast by Technology
8.4.7.26. Rest of Asia-Pacific market size and forecast by Product
8.4.7.27. Rest of Asia-Pacific market size and forecast by Application
8.4.7.28. Rest of Asia-Pacific market size and forecast by End Users
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast by country
8.5.4. Market size and forecast by Technology
8.5.5. Market size and forecast by Product
8.5.6. Market size and forecast by Application
8.5.7. Market size and forecast by End Users
8.5.7.1. Brazil market size and forecast by Technology
8.5.7.2. Brazil market size and forecast by Product
8.5.7.3. Brazil market size and forecast by Application
8.5.7.4. Brazil market size and forecast by End Users
8.5.7.5. Saudi Arabia market size and forecast by Technology
8.5.7.6. Saudi Arabia market size and forecast by Product
8.5.7.7. Saudi Arabia market size and forecast by Application
8.5.7.8. Saudi Arabia market size and forecast by End Users
8.5.7.9. South Africa market size and forecast by Technology
8.5.7.10. South Africa market size and forecast by Product
8.5.7.11. South Africa market size and forecast by Application
8.5.7.12. South Africa market size and forecast by End Users
8.5.7.13. Rest of LAMEA market size and forecast by Technology
8.5.7.14. Rest of LAMEA market size and forecast by Product
8.5.7.15. Rest of LAMEA market size and forecast by Application
8.5.7.16. Rest of LAMEA market size and forecast by End Users

CHAPTER 9 COMPANY PROFILES
9.1. AGILENT TECHNOLOGIES, INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. BIOMERIEUX S.A.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. BIO-RAD LABORATORIES, INC.
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. F. HOFFMANN-LA ROCHE AG (ROCHE)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. FLUIDIGM CORPORATION
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. LGC LIMITED
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. QIAGEN N.V.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.8. SYGNIS AG
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. TAKARA BIO INC.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. THERMO FISHER SCIENTIFIC INC.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll